201 related articles for article (PubMed ID: 8076772)
21. Surveillance of familial adenomatous polyposis patients after ileorectal anastomosis or ileoanal pouch anastomosis.
Tytgat GN
Gastrointest Endosc Clin N Am; 1997 Jan; 7(1):111-27. PubMed ID: 8995117
[TBL] [Abstract][Full Text] [Related]
22. [Rectal micropolyps after total colectomy in familial polyposis. Efficacy of sulindac].
Charneau J; D'Aubigny N; Burtin P; Person B; Boyer J
Gastroenterol Clin Biol; 1990; 14(2):153-7. PubMed ID: 2158470
[TBL] [Abstract][Full Text] [Related]
23. Long-term treatment with sulindac in familial adenomatous polyposis: a prospective cohort study.
Cruz-Correa M; Hylind LM; Romans KE; Booker SV; Giardiello FM
Gastroenterology; 2002 Mar; 122(3):641-5. PubMed ID: 11874996
[TBL] [Abstract][Full Text] [Related]
24. Regular endoscopic surveillance and polypectomy is effective in managing rectal adenoma progression following colectomy and ileorectal anastomosis in patients with familial adenomatous polyposis.
Anele CC; Xiang J; Martin I; Hawkins M; Man R; Clark SK; Faiz OD; Latchford A
Colorectal Dis; 2022 Mar; 24(3):277-283. PubMed ID: 34741380
[TBL] [Abstract][Full Text] [Related]
25. Risk of cancer in the rectal remnant after ileorectal anastomosis in patients with familial adenomatous polyposis: single center experience.
Maehata Y; Esaki M; Nakamura S; Hirahashi M; Ueki T; Iida M; Kitazono T; Matsumoto T
Dig Endosc; 2015 May; 27(4):471-478. PubMed ID: 25495028
[TBL] [Abstract][Full Text] [Related]
26. The NSAID sulindac reverses rectal adenomas in colectomized patients with familial adenomatous polyposis: clinical results of a dose-finding study on rectal sulindac administration.
Winde G; Gumbinger HG; Osswald H; Kemper F; Bünte H
Int J Colorectal Dis; 1993 Mar; 8(1):13-7. PubMed ID: 8388011
[TBL] [Abstract][Full Text] [Related]
27. Long-term outcome of metachronous rectal cancer following ileorectal anastomosis for familial adenomatous polyposis.
Yamaguchi T; Yamamoto S; Fujita S; Akasu T; Moriya Y
J Gastrointest Surg; 2010 Mar; 14(3):500-5. PubMed ID: 19937474
[TBL] [Abstract][Full Text] [Related]
28. A Decision Analysis for Rectal-Sparing Familial Adenomatous Polyposis: Total Colectomy With Ileorectal Anastomosis Versus Proctocolectomy With IPAA.
Melnitchouk N; Saadat LV; Bleday R; Goldberg JE
Dis Colon Rectum; 2019 Jan; 62(1):27-32. PubMed ID: 30394986
[TBL] [Abstract][Full Text] [Related]
29. Factors affecting the risk of rectal cancer following rectum-preserving surgery in patients with familial adenomatous polyposis.
Iwama T; Mishima Y
Dis Colon Rectum; 1994 Oct; 37(10):1024-6. PubMed ID: 7924709
[TBL] [Abstract][Full Text] [Related]
30. Familial adenomatous polyposis and duodenal lymphoma: report of a case.
Frizelle FA; Hemmings CT; Whitehead MR; Spigelman AD
Dis Colon Rectum; 2003 Dec; 46(12):1698-701. PubMed ID: 14668598
[TBL] [Abstract][Full Text] [Related]
31. Rectal cancer after sulindac therapy for a sporadic adenomatous colonic polyp.
Matsuhashi N; Nakajima A; Shinohara K; Oka T; Yazaki Y
Am J Gastroenterol; 1998 Nov; 93(11):2261-6. PubMed ID: 9820411
[TBL] [Abstract][Full Text] [Related]
32. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis.
Giardiello FM; Hamilton SR; Krush AJ; Piantadosi S; Hylind LM; Celano P; Booker SV; Robinson CR; Offerhaus GJ
N Engl J Med; 1993 May; 328(18):1313-6. PubMed ID: 8385741
[TBL] [Abstract][Full Text] [Related]
33. Balance between endoscopic and genetic information in the choice of ileorectal anastomosis for familial adenomatous polyposis.
Valanzano R; Ficari F; Curia MC; Aceto G; Veschi S; Cama A; Battista P; Tonelli F
J Surg Oncol; 2007 Jan; 95(1):28-33. PubMed ID: 17192888
[TBL] [Abstract][Full Text] [Related]
34. Efficacy and safety of eflornithine (CPP-1X)/sulindac combination therapy versus each as monotherapy in patients with familial adenomatous polyposis (FAP): design and rationale of a randomized, double-blind, Phase III trial.
Burke CA; Dekker E; Samadder NJ; Stoffel E; Cohen A
BMC Gastroenterol; 2016 Aug; 16(1):87. PubMed ID: 27480131
[TBL] [Abstract][Full Text] [Related]
35. Regression of rectal adenomas after colectomy and ileorectal anastomosis for familial adenomatous polyposis.
Nicholls RJ; Springall RG; Gallagher P
Br Med J (Clin Res Ed); 1988 Jun; 296(6638):1707-8. PubMed ID: 2840998
[No Abstract] [Full Text] [Related]
36. Sulindac induced regression of colorectal adenomas in familial adenomatous polyposis: evaluation of predictive factors.
Giardiello FM; Offerhaus JA; Tersmette AC; Hylind LM; Krush AJ; Brensinger JD; Booker SV; Hamilton SR
Gut; 1996 Apr; 38(4):578-81. PubMed ID: 8707091
[TBL] [Abstract][Full Text] [Related]
37. Clinical and genomic influence of sulindac on rectal mucosa in familial adenomatous polyposis.
Winde G; Schmid KW; Brandt B; Müller O; Osswald H
Dis Colon Rectum; 1997 Oct; 40(10):1156-68; discussion 1168-9. PubMed ID: 9336110
[TBL] [Abstract][Full Text] [Related]
38. Long-term follow-up after colectomy and ileorectal anastomosis in familial adenomatous polyposis coli. Is there still a place for the procedure?
Slors JF; den Hartog Jager FC; Trum JW; Taat CW; Brummelkamp WH
Hepatogastroenterology; 1989 Apr; 36(2):109-12. PubMed ID: 2543616
[TBL] [Abstract][Full Text] [Related]
39. Sulindac for polyposis of the colon.
Waddell WR; Ganser GF; Cerise EJ; Loughry RW
Am J Surg; 1989 Jan; 157(1):175-9. PubMed ID: 2535920
[TBL] [Abstract][Full Text] [Related]
40. Rectal mucosal ornithine decarboxylase activity in familial adenomatous polyposis after ileorectal anastomosis.
Patchett SE; Alstead EM; Trzeciak L; Wocial T; Phillips RK; Farthing MJ
Gut; 1994 Nov; 35(11):1624-6. PubMed ID: 7828986
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
